Insider · CIK 0001123617
HARDMAN NORMAN PHD
Reports to the SEC for 1 company · CHARLOTTE, NC
Transactions
4
Companies
1
Filings
4
CIK
0001123617
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2012-01-25 | Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award | — |
| 2011-01-11 | Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award | — |
| 2010-01-19 | Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award | — |
| 2009-01-22 | Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4HARDMAN NORMAN PHD0001181431-12-004258SEC(opens sec.gov)
- 4HARDMAN NORMAN PHD0001181431-11-003484SEC(opens sec.gov)
- 4HARDMAN NORMAN PHD0001181431-10-004173SEC(opens sec.gov)
- 4Chelsea Therapeutics International, Ltd.0001181431-09-004810SEC(opens sec.gov)
Companies
Address
3530 TORINGDON WAY SUTE 200
CHARLOTTE, NC, 28277